Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
1998-09-03
Original market date: See footnote 1
1993-12-31
Product name:
HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML
DIN:
01935941
Product Monograph/Veterinary Labelling:
Date:
2019-07-15
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
B. BRAUN MEDICAL INC
824 Twelfth Avenue
Bethlehem
Pennsylvania
United States
18018
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
4
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
20:12.04.16
Anatomical Therapeutic Chemical (ATC): See footnote 4
B01AB51 HEPARIN, COMBINATIONS
Active ingredient group (AIG) number:See footnote5
0423088001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| CITRIC ACID | 93 MG / 100 ML |
| DEXTROSE | 5 G / 100 ML |
| HEPARIN SODIUM | 5000 UNIT / 100 ML |
| SODIUM PHOSPHATE DIBASIC | 410 MG / 100 ML |